<?xml version="1.0" encoding="UTF-8"?>
<itemContainer xmlns="http://omeka.org/schemas/omeka-xml/v5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://omeka.org/schemas/omeka-xml/v5 http://omeka.org/schemas/omeka-xml/v5/omeka-xml-5-0.xsd" uri="https://neomed.omeka.net/items/browse?tags=Refractive+error&amp;output=omeka-xml" accessDate="2026-04-12T02:18:25-04:00">
  <miscellaneousContainer>
    <pagination>
      <pageNumber>1</pageNumber>
      <perPage>40</perPage>
      <totalResults>1</totalResults>
    </pagination>
  </miscellaneousContainer>
  <item itemId="10814" public="1" featured="1">
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="53">
          <name>URL Address</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="140677">
              <text>&lt;a href="http://doi.org/10.1007/s40123-019-00217-w" target="_blank" rel="noreferrer noopener"&gt;http://doi.org/10.1007/s40123-019-00217-w&lt;/a&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Rights</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="140679">
              <text>Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="55">
          <name>Pages</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="140680">
              <text>589-598</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="56">
          <name>Issue</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="140681">
              <text>4</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="57">
          <name>Volume</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="140682">
              <text>8</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="59">
          <name>ISSN</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="140683">
              <text>2193-8245</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="58">
          <name>Search for Full-text</name>
          <description>Locate full-text within NEOMED Library's e-journal collections</description>
          <elementTextContainer>
            <elementText elementTextId="140684">
              <text>&lt;a href="http://ezproxy.neomed.idm.oclc.org/login?url=http://doi.org/10.1007/s40123-019-00217-w" target="_blank" rel="noreferrer noopener"&gt;NEOMED Full-text Holding (if available) - Proxy DOI: 10.1007/s40123-019-00217-w&lt;/a&gt;</text>
            </elementText>
            <elementText elementTextId="140685">
              <text>&lt;p&gt;Users with a NEOMED Library login can search for full-text journal articles at the following url: &lt;a href="https://libraryguides.neomed.edu/home"&gt;https://libraryguides.neomed.edu/home&lt;/a&gt;&lt;/p&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="140669">
                <text>Atropine 0.01% Eye Drops for Myopia Control in American Children: A Multiethnic Sample Across Three US Sites</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="140670">
                <text>Ophthalmology And Therapy</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="140671">
                <text>2019</text>
              </elementText>
              <elementText elementTextId="140672">
                <text>2019-12</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="140673">
                <text>Atropine; Childhood myopia; Eye drops; Myopia; Refractive error; Side effects</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="140674">
                <text>Larkin G  Luke; Tahir Alifiya; Epley K  David; Beauchamp Cynthia L; Tong John T; Clark Robert A</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="140675">
                <text>INTRODUCTION: Topical atropine eye drops at low concentrations have been shown to slow myopia progression in East Asian studies. This study explored the effect of atropine 0.01% eye drops on controlling myopia progression in a multiethnic cohort of children in the USA. METHODS: A multicenter retrospective case-control study (n = 198) quantified the effect of adding nightly atropine 0.01% eye drops to treatment as usual on the progression of childhood (ages 6-15 years) myopia. Cases included all children treated with atropine for at least 1 year. Controls were matched to cases on both age (± 6 months) and baseline spherical equivalent refraction (SER) (± 0.50 diopters, D) at treatment initiation. The primary endpoint was the average SER myopia progression after 1, 1.5, and 2 years of therapy. A secondary outcome was the percentage of subjects with a clinically significant worsening of myopia, defined as a greater than - 0.75 D SER increase in myopia. RESULTS: The average baseline SERs for the atropine (n = 100) and control (n = 98) groups were similar (- 3.1 ± 1.9 D and - 2.8 ± 1.6 D, respectively) (p = 0.23). The average SER increase from baseline was significantly less for the atropine group than the control group at year 1 (- 0.2 ± 0.8 D compared with - 0.6 ± 0.4 D, p &lt; 0.001) and at year 2 (- 0.3 ± 1.1 D compared with - 1.2 ± 0.7 D, p &lt; 0.001). Secondary analysis at year 2 revealed that 80% of the control group vs. 37% of the atropine group experienced clinically significant worsening myopia of at least - 0.75 D (p &lt; 0.001). There were no major safety issues reported in either group. CONCLUSION: Similar to results reported in Asia, atropine 0.01% eye drops significantly reduced myopia progression in a cohort of US children over 2 years of treatment. FUNDING: Nevakar, Inc. Plain language summary available for this article.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="140676">
                <text>&lt;a href="http://doi.org/10.1007/s40123-019-00217-w" target="_blank" rel="noreferrer noopener"&gt;10.1007/s40123-019-00217-w&lt;/a&gt;</text>
              </elementText>
              <elementText elementTextId="140678">
                <text>PMID: 31602553</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="140686">
                <text>Journal Article</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1229">
        <name>2019</name>
      </tag>
      <tag tagId="49963">
        <name>Atropine</name>
      </tag>
      <tag tagId="49972">
        <name>Beauchamp Cynthia L</name>
      </tag>
      <tag tagId="49964">
        <name>Childhood myopia</name>
      </tag>
      <tag tagId="49974">
        <name>Clark Robert A</name>
      </tag>
      <tag tagId="32955">
        <name>Department of Emergency Medicine</name>
      </tag>
      <tag tagId="49971">
        <name>Epley K  David</name>
      </tag>
      <tag tagId="49965">
        <name>Eye drops</name>
      </tag>
      <tag tagId="34647">
        <name>Journal Article</name>
      </tag>
      <tag tagId="49969">
        <name>Larkin G  Luke</name>
      </tag>
      <tag tagId="49966">
        <name>Myopia</name>
      </tag>
      <tag tagId="32953">
        <name>NEOMED College of Medicine</name>
      </tag>
      <tag tagId="50535">
        <name>November 2019 Update</name>
      </tag>
      <tag tagId="49962">
        <name>Ophthalmology And Therapy</name>
      </tag>
      <tag tagId="49967">
        <name>Refractive error</name>
      </tag>
      <tag tagId="49968">
        <name>Side effects</name>
      </tag>
      <tag tagId="50548">
        <name>Summa Health System Akron City Hospital</name>
      </tag>
      <tag tagId="49970">
        <name>Tahir Alifiya</name>
      </tag>
      <tag tagId="49973">
        <name>Tong John T</name>
      </tag>
    </tagContainer>
  </item>
</itemContainer>
